Ambu stock gets a new board observer with Olympus experience

Published on 10/04/2026 at 22:13 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Ambu stock reported DKK 1.64 billion in Q3 2026 revenue, up 8.8 percent year over year. On September 28, Ambu named a former Olympus executive as board observer.

Isometrische Wertschöpfungskette der Medizintechnik-Branche — Ambu A/S (DK0060946788) stellt isometrisch die Wertschöpfungskette der Medizintechnik von Forschung bis Krankenhausversorgung dar, Illustration mit AI erstellt.

Ambu (ISIN DK0060946788) closed at DKK 67.35 on Nasdaq Copenhagen on October 2, 2026, up DKK 0.25 or 0.37 percent from the prior close. The company appointed former Olympus executive Nacho Abia as a board observer on September 28, according to Ambu.

Leadership adds endoscopy experience

Abia is the current CEO of Grifols and previously held senior executive roles at Olympus, including chief operating officer and CEO of Olympus Americas. Ambu plans to propose him for election to the board at its annual general meeting on December 2, 2026, per Ambu.

The appointment adds sector experience at a point when Ambu is expanding single-use endoscopy. The company describes itself as a market leader in single-use endoscopy, while its portfolio also covers anesthesia, neurology and cardiology devices.

Q3 revenue reached DKK 1.64 billion

Ambu reported Q3 2026 revenue of DKK 1.64 billion for the period ended June 30, up 8.8 percent from DKK 1.51 billion in Q3 2025. Net income rose 27 percent to DKK 156 million, while earnings per share increased to DKK 0.59 from DKK 0.46, according to Investing.com.

The earnings mix was constructive but not uniform: revenue matched the published estimate of DKK 1.65 billion, while EPS of DKK 0.59 trailed the DKK 0.62 estimate. That gap keeps execution and margin delivery central to the investment case.

UBS target remains above the stock

UBS cut its Ambu rating to Neutral from Buy on September 15, 2026, and reduced its price target to DKK 72 from DKK 96, according to MarketScreener. UBS cited repeated forecast cuts and execution concerns around growth and margins.

The broader consensus is Hold from 8 analysts, with an average target of DKK 81.77, according to MarketScreener. That average target is 21.4 percent above the October 2 closing price of DKK 67.35, while the UBS target is 6.9 percent higher.

Stock closed near the lower half of its range

Ambu stock closed at DKK 67.35 on October 2, 2026, after trading between DKK 65.50 and DKK 67.80 during the session. Its 52-week range was DKK 56.25 to DKK 111.80, and volume reached 619,487 shares.